Geron Corp (GERN)
3.765
+0.10
(+2.87%)
USD |
NASDAQ |
Nov 18, 16:00
3.765
0.00 (0.00%)
After-Hours: 20:00
Geron Enterprise Value: 1.957B for Nov. 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 15, 2024 | 1.957B |
| November 14, 2024 | 1.987B |
| November 13, 2024 | 2.083B |
| November 12, 2024 | 2.144B |
| November 11, 2024 | 2.235B |
| November 08, 2024 | 2.313B |
| November 07, 2024 | 2.337B |
| November 06, 2024 | 2.325B |
| November 05, 2024 | 2.295B |
| November 04, 2024 | 2.313B |
| November 01, 2024 | 2.223B |
| October 31, 2024 | 2.223B |
| October 30, 2024 | 2.247B |
| October 29, 2024 | 2.313B |
| October 28, 2024 | 2.289B |
| October 25, 2024 | 2.193B |
| October 24, 2024 | 2.156B |
| October 23, 2024 | 2.199B |
| October 22, 2024 | 2.163B |
| October 21, 2024 | 2.126B |
| October 18, 2024 | 2.211B |
| October 17, 2024 | 2.193B |
| October 16, 2024 | 2.259B |
| October 15, 2024 | 2.271B |
| October 14, 2024 | 2.241B |
| Date | Value |
|---|---|
| October 11, 2024 | 2.355B |
| October 10, 2024 | 2.355B |
| October 09, 2024 | 2.289B |
| October 08, 2024 | 2.319B |
| October 07, 2024 | 2.247B |
| October 04, 2024 | 2.349B |
| October 03, 2024 | 2.343B |
| October 02, 2024 | 2.422B |
| October 01, 2024 | 2.404B |
| September 30, 2024 | 2.482B |
| September 27, 2024 | 2.475B |
| September 26, 2024 | 2.391B |
| September 25, 2024 | 2.439B |
| September 24, 2024 | 2.494B |
| September 23, 2024 | 2.301B |
| September 20, 2024 | 2.560B |
| September 19, 2024 | 2.578B |
| September 18, 2024 | 2.445B |
| September 17, 2024 | 2.463B |
| September 16, 2024 | 2.355B |
| September 13, 2024 | 2.439B |
| September 12, 2024 | 2.403B |
| September 11, 2024 | 2.367B |
| September 10, 2024 | 2.337B |
| September 09, 2024 | 2.379B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
38.44M
Minimum
Mar 18 2020
2.720B
Maximum
Jul 16 2024
763.88M
Average
454.70M
Median
Enterprise Value Benchmarks
| Emergent BioSolutions Inc | 931.00M |
| NovaBay Pharmaceuticals Inc | 2.764M |
| Palatin Technologies Inc | 15.88M |
| iBio Inc | 6.468M |
| Theriva Biologics Inc | -12.46M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -26.45M |
| Revenue (Quarterly) | 28.27M |
| Total Expenses (Quarterly) | 56.49M |
| EPS Diluted (Quarterly) | -0.04 |
| Gross Profit Margin (Quarterly) | 98.39% |
| Profit Margin (Quarterly) | -93.55% |
| Earnings Yield | -8.50% |
| Normalized Earnings Yield | -8.499 |